| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/05/1998 | WO1998008513A1 Amorphous benzothiophenes, methods of preparation, and methods of use |
| 03/05/1998 | WO1998008512A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor |
| 03/05/1998 | WO1998008503A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | WO1997046226A3 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS |
| 03/05/1998 | WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 03/05/1998 | CA2599944A1 P-selectin ligand proteins |
| 03/05/1998 | CA2265049A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 03/05/1998 | CA2264045A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2264044A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263999A1 Integrin antagonists |
| 03/05/1998 | CA2263998A1 Compositions and methods for administering integrin receptor antagonists |
| 03/05/1998 | CA2263932A1 1,4-heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263928A1 Substituted cyclic amine metalloprotease inhibitors |
| 03/05/1998 | CA2263914A1 Bidentate metalloprotease inhibitors |
| 03/05/1998 | CA2263826A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor |
| 03/05/1998 | CA2263824A1 Cd95 regulatory gene sequences and transcription factors |
| 03/05/1998 | CA2263685A1 Use of glp-1 or analogs in treatment of myocardial infarction |
| 03/05/1998 | CA2263175A1 Amorphous benzothiophenes, methods of preparation, and methods of use |
| 03/04/1998 | EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase |
| 03/04/1998 | EP0826682A1 Amorphous benzothiophenes, methods of preparation, and methods of use |
| 03/04/1998 | EP0826680A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/04/1998 | EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods |
| 03/04/1998 | EP0826374A2 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 03/04/1998 | EP0825994A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators |
| 03/04/1998 | EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
| 03/04/1998 | EP0825862A1 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
| 03/04/1998 | EP0825848A1 Novel collagen formulations |
| 03/04/1998 | CN1175262A Novel receptor |
| 03/04/1998 | CN1175259A Low molecular weight bicyclic thrombin inhibitors |
| 03/04/1998 | CN1175252A Imidazole derivatives as protein kinase inhibitors in particular egf-rthyrosine kinase |
| 03/04/1998 | CN1175250A Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as artive ingredient |
| 03/04/1998 | CN1175246A Substituted azetidin-2-ones for treatment of atherosclerosis |
| 03/04/1998 | CN1175210A 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 03/04/1998 | CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/04/1998 | CN1174835A Salts of ethyl 3 -(2 -(4 -(4 -(amino-imino-methyl) phenyl) -4 -methyl -2, 5 -dioxo -imidazolidin -1 -yl) acetylamino) -3 -phenylpropionate |
| 03/04/1998 | CN1174833A Phenyl substituted alkenocarboxylic guanidine, preparation method, application as medicine or diagnostic agent adn medicine containing it |
| 03/03/1998 | US5723606 Condensed benzazepine derivative and pharmaceutical composition thereof |
| 03/03/1998 | US5723583 Antibody containing sialyl lewis X determinants |
| 03/03/1998 | US5723499 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 03/03/1998 | US5723484 Benzopyran compounds as 5-HT2C receptor antagonists |
| 03/03/1998 | US5723480 Adhesion receptor antagonists III |
| 03/03/1998 | US5723465 Inhibitors for cell adhesion and cellular infiltration |
| 03/03/1998 | US5723460 Potent and selective phosphodiesterase type iv inhibitors; useful in the prophylaxis and treatment of disease such as asthma where unwanted inflammatory response or muscular spasm is present |
| 03/03/1998 | US5723458 1,4-benzothiazepines |
| 03/03/1998 | US5723456 Therapeutic treatment for cardiovascular diseases |
| 03/03/1998 | US5723449 Antisecretory agents and anticarcinogenic agents |
| 03/03/1998 | US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity |
| 02/28/1998 | CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods |
| 02/28/1998 | CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | WO1998007751A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma |
| 02/26/1998 | WO1998007696A1 Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
| 02/26/1998 | WO1998007695A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 02/26/1998 | WO1998007694A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/26/1998 | WO1998007449A2 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect |
| 02/26/1998 | WO1998007420A1 Neuropeptide-y ligands |
| 02/26/1998 | WO1998007417A1 Pharmaceutical composition comprising coenzyme q¿10? |
| 02/26/1998 | WO1998007321A1 Method for inhibiting the expression of fas |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997038966A3 Cytoprotective compounds |
| 02/26/1998 | DE19633268A1 Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung Polymeric bile acid Resorptionsinhibitoren with concomitant bile acid Adsorberwirkung |
| 02/26/1998 | CA2268051A1 Neuropeptide-y ligands |
| 02/26/1998 | CA2264220A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 02/26/1998 | CA2264178A1 Method for inhibiting the expression of fas |
| 02/26/1998 | CA2263671A1 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect |
| 02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/25/1998 | EP0825260A2 Arginase II |
| 02/25/1998 | EP0825259A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp |
| 02/25/1998 | EP0825197A2 New 6-hydroxy and 6-oxo-anstro-stane derivatives active on the cardiovascular system and pharmaceutical compositions containing same |
| 02/25/1998 | EP0825185A1 Pyridine fused to a bicyclic ring |
| 02/25/1998 | EP0825178A1 Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them |
| 02/25/1998 | EP0825177A1 New seco-D steroids active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/25/1998 | EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
| 02/25/1998 | EP0824523A1 Nitric oxide synthase inhibitors derived from cyclic amidines |
| 02/25/1998 | EP0824515A1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them |
| 02/25/1998 | CN1174554A Rapamycin 42-oximes and hydroxylamines |
| 02/25/1998 | CN1174548A Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/25/1998 | CN1174513A Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 02/25/1998 | CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 02/25/1998 | CN1174509A Gene transfer-mediated angiogenesis therapy |
| 02/25/1998 | CN1174196A Heterocyclic-fused pyridines |
| 02/25/1998 | CN1174190A Diaryl alkane derivatives containing alicyclic group, their preparation and their therapeutic and prophylactic uses |
| 02/25/1998 | CN1174055A Medicine for raising blood pressure and its preparation |
| 02/25/1998 | CN1037512C Imidazolyl-substituted cyclohexane derivatives, prep. and use thereof |
| 02/24/1998 | US5721365 N-substituted piperazine NONOates |
| 02/24/1998 | US5721276 Treating disorders of melatoninergic system |
| 02/24/1998 | US5721255 Useful for preventing pain, anxiety, migrane, schizophrenia, asthma, rheumatoid arthritis, fibrositis, or ulcerative colitis in mammal |
| 02/24/1998 | US5721249 Administering to treat angina |
| 02/24/1998 | US5721248 Calcium agonists; treating cardiovascular disorders |
| 02/24/1998 | US5721244 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 02/24/1998 | US5721238 2,8-disubstituted quinazolinones |
| 02/24/1998 | US5721237 Administering for the selective treatment of cell growth and differentiation |
| 02/24/1998 | US5721227 17-aryl and 17-heterocyclyl-14β-5α-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 02/24/1998 | US5721222 Inhibitors of human leukocyte elastase |
| 02/24/1998 | US5721217 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
| 02/24/1998 | US5720956 Method of controlling the reactivity of human blood platelets by oral administration of the extract of the maritime pine (pycnogenol) |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |